Up to now, data available in osteosarcoma, only pointed out the importance of the presence of the Ser168 residue of CD99: Ser168 is required for the CD99wt-mediated inhibition of migration and metastatization of osteosarcoma and prostate cancer cells [22]. This evidence concerns the gene CD99 and prostate carcinoma.